Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 1997

View Archived Issues

Mylan enters distribution agreement for ranitidine

Repligen identifies angiogenic growth factor inhibitors

Merck KGaA discloses novel ET antagonists

RPR prepares novel transfection agents

Ilex Oncology: Q2 1997 highlights

Statins protect against stroke and CVD

InSite Vision: Q2 1997 highlights

Melarsoprol normalizes cytokine levels in human African trypanosomiasis

Roche seeks U.S. and European approval for Corange takeover

Unigene Laboratories and Parke-Davis to develop oral calcitonin for osteoporosis

Papaverine/phentolamine compared to PGE1 for erectile dysfunction

Advantage-24 safe for evaluation in HIV prevention

Picotamide suppresses ACE inhibitor-induced cough

Review of preclinical and clinical studies with xanomeline

SangStat Medical reports encouraging phase III results with Thymoglobulin

Talsaclidine: favorable preclinical and pharmacokinetic profile

Vivus launches new device for erectile dysfunction in the U.S.

Sepracor reports promising phase II results for norastemizole

Antiherpes activity of naturally occurring flavone alone and in combination with aciclovir

Pharmacopeia receives SBIR grant for development of plasmepsin inhibitors

Jenner licenses emulsion formulation from Walter Reed

D-Pharm reports results from toxicity study for neuroprotective compound

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...